1. Academic Validation
  2. Antifungal activity of magnolol and honokiol

Antifungal activity of magnolol and honokiol

  • Arch Pharm Res. 2000 Feb;23(1):46-9. doi: 10.1007/BF02976465.
K H Bang 1 Y K Kim B S Min M K Na Y H Rhee J P Lee K H Bae
Affiliations

Affiliation

  • 1 R & D Center, Kolon Pharmaceutical Inc., Taejon, Korea.
Abstract

Two neolignan compounds, magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl, 1) and honokiol (5,5'-diallyl-2,4'-dihydroxybiphenyl, 2), were isolated from the stem bark of Magnolia obovata and evaluated for Antifungal activity against various human pathogenic fungi. Compound 1 and 2 showed significant inhibitory activities against Trichophyton mentagrophytes, Microsporium gypseum, Epidermophyton floccosum, Aspergillus niger, Cryptococcus neoformans, and Candida albicans with minimum inhibitory concentrations (MIC) in a range of 25-100 microg/ml. Therefore, compound 1 and 2 could be used as lead compounds for the development of novel Antifungal agents.

Figures
Products